STOCKHOLM, Aug. 24, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the results of the CONDUCT study will be presented orally at two leading gastroenterology conferences; the United European Gastroenterology Week (UEGW) and the American College of...
from PR Newswire: https://ift.tt/2QkzvpO
No comments:
Post a Comment